The relevance of remnant cholesterol as a guide for lipid management in Indian subjects undergoing coronary revascularization
Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2025
DOI: 10.1016/j.dsx.2024.103183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2025. Verfasst von Manish Bansal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical and Preventive Cardiology, Medanta- The Medicity, Gurgaon, India. Electronic address: manishaiims@hotmail.com. Hauptthemen laut MEDLINE: Cholesterol, Triglycerides, Coronary Artery Disease, Myocardial Revascularization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The atherogenic potential of remnant cholesterol, which refers to the cholesterol content of triglyceride-rich, non-low-density lipoprotein (LDL) particles in circulation, has gained increasing attention recently. Unfortunately, very limited information is available regarding remnant cholesterol levels in Indian subjects. METHODS: This was a retrospective study conducted at a premier, tertiary care center in North India. A total of 3064 consecutive subjects [mean age 61.3 ± 10.3 years, 2550 (83.2%) men] with newly diagnosed coronary artery disease (CAD) undergoing coronary revascularization were included. Enzymatic assays were used for measuring various lipid parameters. Remnant cholesterol was calculated by subtracting LDL cholesterol (LDL-C) and high-density lipoprotein cholesterol from total cholesterol. A value >30 mg/dL was considered elevated. RESULTS: The mean LDL-C was 79.1 ± 33.1 mg/dL with 46.4% of all subjects having LDL-C 30 mg/dL. Only 4.5% of the patients with LDL-C 200 mg/dL. CONCLUSION: Our study shows that in a North-Indian population with CAD, elevated remnant cholesterol was present in only a small proportion. The prevalence of elevated remnant cholesterol decreased further as the LDL-C control improved. These findings suggest that elevated remnant cholesterol may not be a clinically relevant therapeutic target in most patients with LDL-C below the currently recommended goals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical and Preventive Cardiology, Medanta- The Medicity, Gurgaon, India. Electronic address: manishaiims@hotmail.com.
- Division of Clinical and Preventive Cardiology, Medanta- The Medicity, Gurgaon, India.
- Division of Interventional Cardiology, Medanta- The Medicity, Gurgaon, India.
- Division of Cardiothoracic Surgery, Medanta- The Medicity, Gurgaon, India.
Zitieren
APA
Bansal, M., Kasliwal, R. R., Chandra, P., Kapoor, R., Chouhan, N., Bhan, A., & Trehan, N. (2025). The relevance of remnant cholesterol as a guide for lipid management in Indian subjects undergoing coronary revascularization. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2024.103183
Vancouver
Bansal M, Kasliwal RR, Chandra P, Kapoor R, Chouhan N, Bhan A, et al. The relevance of remnant cholesterol as a guide for lipid management in Indian subjects undergoing coronary revascularization. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2025. doi:10.1016/j.dsx.2024.103183
BibTeX
@article{Bansal2025,
author = {Bansal, Manish and Kasliwal, Ravi R and Chandra, Praveen and Kapoor, Rajneesh and Chouhan, Nagendra and Bhan, Anil and Trehan, Naresh},
title = {The relevance of remnant cholesterol as a guide for lipid management in Indian subjects undergoing coronary revascularization},
journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
year = {2025},
doi = {10.1016/j.dsx.2024.103183}
}
EUVIMED